Fas-p53 pathway drives metabolic dysfunction and obesity-linked insulin resistance

Fol­low­ing the FDA’s May re­lease of long-await­ed draft guid­ance ex­plain­ing how com­pa­nies can win des­ig­na­tions for cer­tain cell and gene ther­a­py “plat­form” tech­nolo­gies, com­pa­nies like

Astel­las is of­fer­ing the promise of “not flash­es” for women go­ing through menopause in its first TV ad­ver­tis­ing for its Veozah brand. The cam­paign for